08.04.2014 Views

slides - Express Scripts

slides - Express Scripts

slides - Express Scripts

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Good Intentions,<br />

Bad Behavior and<br />

A Better Tomorrow<br />

Steve Miller MD<br />

SVP and Chief Medical Officer


What a Year 2010 Was!<br />

Healthcare Reform Passes<br />

Election Implementation Results Begins<br />

Watson Republican Beats majorities Humans<br />

in Carbon-based the House and life-forms in<br />

Charlie Sheen<br />

many shown more to be states<br />

Any questions? inferior at<br />

Jeopardy!<br />

Outcomes Conference 2011<br />

2


“The good physician<br />

treats the disease;<br />

the great physician<br />

treats the patient.”<br />

Sir William Osler<br />

Founding Professor of Medicine<br />

Johns Hopkins Hospital<br />

1849 - 1919<br />

Outcomes Conference 2011<br />

3


Medical Training Before Dr. Osler<br />

•Classrooms were<br />

amphitheaters<br />

•Students had no contact with<br />

patients<br />

•Physicians met their first<br />

patients only after graduating<br />

from medical school<br />

Outcomes Conference 2011<br />

4


Dr. Osler Introduced Bedside Instruction<br />

Outcomes Conference 2011<br />

5


Dr. Osler Introduced Medical Internships<br />

Outcomes Conference 2011<br />

6


We Are Still Learning from Dr. Osler<br />

“It is much more important<br />

to know what sort of<br />

a patient has a disease<br />

than what sort of<br />

a disease a patient has.”<br />

Forgetting Dr. Osler’s lessons<br />

has driven an<br />

explosion in waste.<br />

Outcomes Conference 2011<br />

7


$400<br />

$403 Billion Wasted in 2010<br />

$350<br />

$300<br />

$250<br />

HD Adherence<br />

$200<br />

$150<br />

$100<br />

$50<br />

$0<br />

HD Mix<br />

Safer<br />

Dispensing<br />

Adherence<br />

Mix<br />

Mix Channel Adherence<br />

Outcomes Conference 2011<br />

8


25%<br />

2010 Overall Drug Trend: 3.6%<br />

20%<br />

15%<br />

10%<br />

Overall<br />

•3.6%<br />

Traditional<br />

•1.4%<br />

Specialty<br />

•19.6%<br />

5%<br />

0%<br />

2006 2007 2008 2009 2010<br />

Overall Drug Trend<br />

Traditional Drug Trend<br />

Specialty Drug Trend<br />

Outcomes Conference 2011<br />

9


Monthly Copay<br />

Member Cost-Share Continues to Fall<br />

$60<br />

25%<br />

$50<br />

$40<br />

$30<br />

$20<br />

$10<br />

22.5% 22.0%<br />

20.2% $54.19<br />

19.3%<br />

$47.76<br />

Overall copays fell by $0.32 per Rx<br />

to a new low member share of<br />

19.3%<br />

$12.47 $12.15 $12.33 $11.98 2.6% 2.6%<br />

20%<br />

15%<br />

10%<br />

5%<br />

Fraction of total Rx cost<br />

$0<br />

Overall Traditional Specialty<br />

2009 2010<br />

Outcomes Conference 2011<br />

0%<br />

10


Drug cost inflation rate<br />

Brand Inflation Climbed to 9.7%<br />

10%<br />

8%<br />

6%<br />

7.6%<br />

Brands<br />

9.7%<br />

0%<br />

-2%<br />

-4%<br />

Generics<br />

-6%<br />

4%<br />

2%<br />

-8%<br />

-10%<br />

-9.0%<br />

-10.2%<br />

0%<br />

-12%<br />

2008 2010 2008 2010<br />

Outcomes Conference 2011<br />

11


Your Decisions Drive<br />

Your Members’ Behaviors<br />

Market and Behavioral Analysis<br />

Market Factors<br />

Prevalence<br />

Cost per prescription<br />

Units per prescription<br />

Patent expirations<br />

New drug entrants<br />

Behavioral Factors<br />

Drug mix<br />

Channel<br />

Therapy adherence<br />

Total Behavioral<br />

Savings Opportunity<br />

Outcomes Conference 2011<br />

12


2010 Overall Drug Trend: 3.6%<br />

Prevalence<br />

0.3%<br />

Drug Cost<br />

4.2%<br />

Units per Rx<br />

0.0%<br />

Patent Expirations<br />

-1.7%<br />

New Drugs<br />

Adherence<br />

0.3%<br />

1.7%<br />

Drug Mix<br />

-1.1%<br />

-2% 0% 2% 4% 6%<br />

Outcomes Conference 2011<br />

13


2010 Overall Drug Trend: 3.6%<br />

Prevalence<br />

0.3%<br />

Market<br />

Factors<br />

Drug Cost<br />

Units per Rx<br />

0.0%<br />

4.2%<br />

Patent Expirations<br />

-1.7%<br />

New Drugs<br />

0.3%<br />

Behavioral<br />

Factors<br />

Adherence<br />

Drug Mix<br />

-1.1%<br />

1.7%<br />

-2% 0% 2% 4% 6%<br />

Outcomes Conference 2011<br />

14


2010 Traditional Drug Trend: 1.4%<br />

Prevalence<br />

-0.7%<br />

Market<br />

Factors<br />

Drug Cost<br />

Units per Rx<br />

0.2%<br />

3.5%<br />

Patent Expirations<br />

-1.9%<br />

New Drugs<br />

0.2%<br />

Behavioral<br />

Factors<br />

Adherence<br />

Drug Mix<br />

-1.7%<br />

1.9%<br />

-2% -1% 0% 1% 2% 3% 4%<br />

Outcomes Conference 2011<br />

15


Obesity Is Now the Norm<br />

Ages 2 - 19<br />

Adults<br />

34%<br />

68%<br />

66%<br />

32%<br />

Normal<br />

http://www.cdc.gov/nchs/fastats/overwt.htm. Accessed March 18, 2011.<br />

Overweight/Obese<br />

Outcomes Conference 2011<br />

16


Obesity and Diabetes Maps Match<br />

Obesity by County, 2007<br />

Behavior Is Key<br />

Diabetes by County, 2007<br />

www.cdc.gov/obesity/data/trends.html. Accessed March 16, 2011.<br />

Outcomes Conference 2011<br />

17


Top Three Traditional Classes<br />

Each Is Linked to Obesity<br />

15%<br />

High Cholesterol<br />

6.3% Trend<br />

Diabetes<br />

12.5% Trend<br />

Cardiovascular<br />

-0.4% Trend<br />

10%<br />

5%<br />

0%<br />

-5%<br />

--10%<br />

Class Trend Market Factors Behavioral Factors<br />

Outcomes Conference 2011


0%<br />

-2%<br />

-4%<br />

Two Other Classes to Watch<br />

Ulcer Disease<br />

Attention Disorders<br />

25%<br />

20%<br />

15%<br />

-6%<br />

-8%<br />

-14%<br />

10%<br />

5%<br />

17%<br />

-10%<br />

0%<br />

-12%<br />

-5%<br />

-14%<br />

-10%<br />

Class Trend Market Factors Behavioral Factors<br />

Outcomes Conference 2011<br />

19


2010 Specialty Drug Trend: 19.6%<br />

Prevalence<br />

7.0%<br />

Market<br />

Factors<br />

Drug Cost<br />

Units per Rx<br />

-0.8%<br />

9.2%<br />

Patent Expirations<br />

-0.1%<br />

New Drugs<br />

1.1%<br />

Behavioral<br />

Factors<br />

Adherence<br />

Drug Mix<br />

0.0%<br />

3.3%<br />

-2% 0% 2% 4% 6% 8% 10%<br />

Outcomes Conference 2011<br />

20


Top Three Specialty Classes<br />

30%<br />

Inflammatory<br />

23.5% Trend<br />

Multiple Sclerosis<br />

25.4% Trend<br />

Cancer<br />

23.7% Trend<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

-5%<br />

Class Trend Market Factors Behavioral Factors<br />

Outcomes Conference 2011


PMPY<br />

Specialty Is More than the<br />

Top Four Traditional Classes Combined<br />

$350<br />

$300<br />

$250<br />

$200<br />

$150<br />

High<br />

Cholesterol<br />

Diabetes<br />

Medical<br />

Benefit<br />

$100<br />

$50<br />

$0<br />

Cardiovascular<br />

Depression<br />

Traditional<br />

Pharmacy<br />

Benefit<br />

Specialty<br />

Outcomes Conference 2011<br />

22


400%<br />

Medical Benefit Is<br />

Growing Out of Control<br />

300%<br />

200%<br />

100%<br />

0%<br />

-100%<br />

Inflammatory<br />

Conditions<br />

Multiple<br />

Sclerosis<br />

Cancer<br />

Pulmonary<br />

HTN<br />

Blood Cell<br />

Deficiency<br />

Pharmacy Benefit<br />

Medical Benefit<br />

ESI DTR 2010: Division of medically billed specialty drug spend by site of<br />

care. Thomson Reuters MarketScan ® Commercial Database, 2005-2008.<br />

Outcomes Conference 2011<br />

23


100%<br />

Specialty Pharmacy Is<br />

Leaving Physicians’ Offices<br />

80%<br />

60%<br />

76% 74%<br />

70%<br />

63%<br />

All Other:<br />

•Emergency Rooms<br />

•Urgent Care Centers<br />

40%<br />

•Inpatient Sites<br />

20%<br />

•Outpatient Facilities<br />

0%<br />

2005 2006 2007 2008<br />

Physicians' Offices<br />

All Other<br />

ESI DTR 2010: Division of medically billed specialty drug spend by site of care.<br />

Thomson Reuters MarketScan ® Commercial Database, 2005-2008.<br />

Outcomes Conference 2011<br />

24


Physician Strategies<br />

Are Vital to Success in Specialty<br />

Outcomes Conference 2011<br />

25


Big Challenges, Big Solutions<br />

Specialty<br />

Pharmacy Benefit<br />

Management<br />

<strong>Express</strong> <strong>Scripts</strong><br />

Medical Benefit<br />

Management<br />

Care Continuum<br />

Specialty<br />

Pharmacy and<br />

Distribution<br />

CuraScript<br />

Outcomes Conference 2011<br />

26


Harness Patients’ Good Intentions…<br />

…and cut 33%<br />

of America’s pharmacy-related waste<br />

Outcomes Conference 2011<br />

27


We Commissioned Harris Interactive<br />

Nationally recognized firm specialized in<br />

assessing consumer attitudes and beliefs<br />

• Representative sample of American adults<br />

• N = 2,099<br />

• Current users of daily prescription medications<br />

• Provided realistic scenarios of various Rx-related<br />

choices (e.g., Home Delivery vs. Retail)<br />

Outcomes Conference 2011<br />

Source: Harris Interactive & <strong>Express</strong> <strong>Scripts</strong>, 2011


If Consumers are Satisfied with<br />

Current Behavior…<br />

~0%<br />

~0%<br />

~0%<br />

of people taking brand-name meds would<br />

rather be taking generics<br />

of people getting maintenance meds in retail<br />

would rather be in Home Delivery<br />

of people going to more expensive retail<br />

stores would switch to lower-cost retail stores<br />

Outcomes Conference 2011


But Harris Interactive<br />

Found That…<br />

~0% 82%<br />

~0% 70%<br />

~0% 40%<br />

of people taking brand-name meds would<br />

rather be taking generics<br />

of people getting maintenance meds in retail<br />

would rather be in Home Delivery<br />

of people going to more expensive retail<br />

stores would switch to lower-cost retail stores<br />

Outcomes Conference 2011


Dr. Osler Would Be Proud<br />

Treat the patient, not the disease.<br />

• Treating diseases, Challenges not patients, lie ahead. has created a<br />

huge amount of waste.<br />

• While Specialty total trend requires is controlled, a holistic challenges approach. lie<br />

ahead.<br />

• Treat the entire<br />

Activate<br />

spectrum<br />

intent.<br />

of the specialty<br />

patient, not just the disease.<br />

• Understanding how to activate intent is crucial to<br />

healthcare success moving forward.<br />

Outcomes Conference 2011<br />

31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!